Page 84 - AN-3-4
P. 84

Advanced Neurology                                           SARS-CoV-2 in age-associated neurodegeneration




            Table 3. (Continued)
            SARS‑CoV‑2     Function in SARS‑CoV‑2 replication          Plausible mechanism contributing   References
            proteins                                                   to neurodegeneration
            Nsp14          Shows exoribonuclease activity; involved RNA capping  N7 methyltransferase activity mimics   70,137,139
                                                                       the cap structure on the true viral
                                                                       RNA, thus making it unrecognized
                                                                       by the host immune system for a long
                                                                       period of time
            Nsp15          Endoribonuclease activity, cleaving RNA substrate at the   Escaping host detection ensures viral   71,137,139
                           3’ of uridines, evading detection by the innate immune   persistence for a longer time in brain
                           response                                    cells
            Nsp16          Responsible for methylating the 5’-end of viral mRNAs,   Ensure viral persistence in the brain   70,137,139
                           generating cap1 structures that shield viral mRNA from   and compromised immune response;
                           MDA5 recognition                            promote viral replication and
                                                                       neurodegeneration
            Spike          Virus-host cell membrane fusion protein binds to ACE2   Highest affinity towards ACE2   137,139
                           and co-receptors                            receptors on the cell surface, thus
                                                                       promoting viral invasion and
                                                                       persistence in the brain; Nsp1
                                                                       binds to the cleaved S1 domain of
                                                                       S protein and amplifies the process
                                                                       of internalization, inducing lipid
                                                                       modification, which may impact BBB
                                                                       permeability
            Nucleocapsid   Viral genome packaging binds to chemokines with the   May promote chronic   137,139
                           ability to block chemotaxis of immune effector cells  neuroinflammation by blocking the
                                                                       chemotaxis of immune effector cells
            Envelope       Viroporin functions as a ligand for TLR2, promotes   May promote chronic   137,139
                           cytokine production, and has an impact on spike protein   neuroinflammation and ER-stress
                           processing and maturation by promoting its retention in
                           the ER-Golgi intermediate compartment
            Membrane       Inhibit IFN-antiviral response; interacts with RIG-I/  May promote chronic   73,74,137,139
                           MDA-5-MAV                                   neuroinflammation
            Orf3a          Viroporin is involved in virus replication; activates NLRP3   Activation of NLRP3 inflammasome   137,139
                           inflammasome complex and IL-1β release; promotes   may result in microglial activation
                           phagophore nucleation by favoring PI3KC3-C1 formation;   and pyroptotic cell death or
                           activates UPR by activating ATF6; promotes the activation   sustained pro-inflammatory response
                           of NF-κB, TLR3 or TLR4, promotes the production   associated with age-associated
                           of HIF-1α through the generation of ROS in the   neurodegeneration.
                           mitochondria and subsequent mitochondrial disruption;
                           enhances the production of pro-inflammatory cytokines
                           IFN-β, IL-6, and IL-1β.
            Orf3b          IFN antagonist                              Promote chronic neuroinflammation  75,137,139
            Orf3c          ORF3c localizes to mitochondria and interacts with   Mitochondrial dysfunction may lead   75,137,139
                           both MAVS and PGAM5 (mt serine/threonine protein   to ROS production and impaired
                           phosphatase); ORF3c expression leads to a reduction in   glycolysis, leading to neuronal death
                           IFNB transcripts and IFN-β protein levels   or deregulation
            Orf3d          Suppress immune activation by an unknown mechanism                         137,139
            Orf6           Binds to NPC proteins (Nup98-Rae1) to inhibit STAT1 and   Generate immune compromised   75,76,137,139
                           IRF3 cytosolic-nuclear translocation thus blocking IFN   microenvironment; induce chronic
                           signaling;                                  neuroinflammation
            Orf7a          Interacts with human CD14 monocytes, leading to   Altered cytokine and chemokine   137,139
                                             +
                           the limitation of antigen presentation; promotes the   profiles may induce CNS as well as
                           up-regulation of certain chemokines such as CCL11,   PNS dysfunction, including cognitive
                           CCL17, CCL19, CCL21, CCL22, CCL25, CCL26, CCL27  and motor impairments
                                                                                                       (Cont’d...)



            Volume 3 Issue 4 (2024)                         11                               doi: 10.36922/an.4267
   79   80   81   82   83   84   85   86   87   88   89